357 related articles for article (PubMed ID: 18617777)
21. Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray.
Xu L; Li YM; Yu CH; Li L; Liu YS; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):138-42. PubMed ID: 16481301
[TBL] [Abstract][Full Text] [Related]
22. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
23. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L
Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215
[TBL] [Abstract][Full Text] [Related]
24. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors.
Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T
J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
27. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapy.
Nasir A; Boulware D; Kaiser HE; Lancaster JM; Coppola D; Smith PV; Hakam A; Siegel SE; Bodey B
In Vivo; 2007; 21(1):35-43. PubMed ID: 17354612
[TBL] [Abstract][Full Text] [Related]
29. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations.
Tomaszewska R; Nowak K; Stachura J
Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116
[TBL] [Abstract][Full Text] [Related]
30. [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance].
Dong M; Zhou JP; Kong FM; Guo KJ; Tian YL; Dong YT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):628-32. PubMed ID: 16274047
[TBL] [Abstract][Full Text] [Related]
31. Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.
Tsiambas E; Kravvaritis C; Tsounis D; Salemis NS; Niotis A; Niotis TH; Rigopoulos DN; Karameris A; Athanasiou AE; Patsouris E; Karakitsos P
J BUON; 2010; 15(1):94-100. PubMed ID: 20414934
[TBL] [Abstract][Full Text] [Related]
32. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
[TBL] [Abstract][Full Text] [Related]
33. Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma.
Cho MH; Yoon JH; Jaegal YJ; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Woo Juhng S; Min KW
Breast; 2006 Jun; 15(3):390-8. PubMed ID: 16169726
[TBL] [Abstract][Full Text] [Related]
34. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
[TBL] [Abstract][Full Text] [Related]
35. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.
Müller-Decker K; Fürstenberger G; Annan N; Kucher D; Pohl-Arnold A; Steinbauer B; Esposito I; Chiblak S; Friess H; Schirmacher P; Berger I
Gastroenterology; 2006 Jun; 130(7):2165-78. PubMed ID: 16762637
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
[TBL] [Abstract][Full Text] [Related]
37. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
Wang W; Bergh A; Damber JE
APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
[TBL] [Abstract][Full Text] [Related]
38. Coordinated upregulation of COX-2 and NF-kappaB is a steady feature of laryngeal carcinogenesis.
Kourelis K; Sotiropoulou-Bonikou G; Vandoros G; Repanti M; Varakis I; Goumas P
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):181-9. PubMed ID: 17264535
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 expression associated with severity of PanIN lesions: a possible link between chronic pancreatitis and pancreatic cancer.
Albazaz R; Verbeke CS; Rahman SH; McMahon MJ
Pancreatology; 2005; 5(4-5):361-9. PubMed ID: 15980665
[TBL] [Abstract][Full Text] [Related]
40. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]